I. Do not use if you have any of the following conditions
II. Consult a doctor before use if you have any of the following conditions
III. Consult a physician, pharmacist, or pharmacist before use if you have any of the following conditions
IV. Other Precautions
- This medication is for external use only. Do not ingest. If accidentally ingested, seek medical attention immediately.
- Do not exceed the recommended dosage.
- Avoid contact with eyes and mucous membranes. If contact occurs, rinse immediately with water. If symptoms persist, seek medical attention immediately.
- Do not apply this medication to skin with rashes or rashes, or to cracked skin, open wounds, or any abnormal skin.
- If you forget to use this medication at the scheduled time, apply the original dosage. Do not double the recommended dosage.
- Before use, if you find that this medicine appears to be spoiled or the packaging is damaged, do not use it.
- After use, please tighten the cap, store in a cool place, avoid direct sunlight, and keep out of reach of children.
V. Warnings
- If the following side effects occur after using this medicine, please discontinue use immediately and consult a doctor, pharmacist, or pharmacist with this instruction manual:
- Skin: If the following symptoms persist after discontinuing use: redness, swelling, itching, or stinging of the skin. (This may occur in 1 ~ 10 out of 100 people.) The skin may be more sensitive to light, and symptoms of sunburn may occur, including itching, redness, swelling, and blisters.
- Pregnant women over 30 weeks of gestation should avoid use.
- Pregnant women between 20 and 30 weeks of gestation must consult a physician before use, and should be treated with the lowest effective dose for the shortest possible duration; if treatment lasts longer than 48 hours, ultrasound monitoring of amniotic fluid may be necessary.
- Pregnant women under 20 weeks of gestation and women who may become pregnant should consult a physician, pharmacist, or pharmacist before use.
(May occur in less than 1 out of 10,000 people) If any of the following symptoms occur after using this medication, please discontinue use immediately and consult a physician: If symptoms do not improve or worsen after use: Skin rash with blisters, hives. (May occur in 1 ~ 10 out of 10,000 people) Wheezing, shortness of breath, wheezing, or difficulty breathing. (May occur in less than 1 out of 10,000 people) Swelling of the face, lips, tongue, or throat. (May occur in less than 1 out of 10,000 people) Non-steroidal anti-inflammatory drugs (NSAIDs) may affect pregnancy and/or embryonic/fetal development. Use in pregnant women over 30 weeks of gestation may lead to premature closure of the fetal ductus cardiacis and pulmonary hypertension; use in pregnant women over 20 weeks of gestation may lead to fetal renal insufficiency, oligohydramnios, and even neonatal kidney damage; use in early pregnancy may increase the risk of miscarriage and heart malformations. Therefore, please follow these recommendations: